Atovaquone [clinicaltrials_resource:f231f35832841c93bdfae03c4071070b]
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients [clinicaltrials:NCT00000655]Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children [clinicaltrials:NCT00000773]Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis [clinicaltrials:NCT00000794]A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides [clinicaltrials:NCT00000802]A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children [clinicaltrials:NCT00000811]An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine [clinicaltrials:NCT00001990]A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia [clinicaltrials:NCT00001991]A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine [clinicaltrials:NCT00001994]A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole [clinicaltrials:NCT00001996]A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX [clinicaltrials:NCT00002340]
intervention [clinicaltrials_vocabulary:intervention]
Atovaquone [clinicaltrials_resource:f231f35832841c93bdfae03c4071070b]
Bio2RDF identifier
f231f35832841c93bdfae03c4071070b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f231f35832841c93bdfae03c4071070b
intervention name [clinicaltrials_vocabulary:intervention-name]
Atovaquone
identifier
clinicaltrials_resource:f231f35832841c93bdfae03c4071070b
title
Atovaquone
@en
type
label
Atovaquone [clinicaltrials_resource:f231f35832841c93bdfae03c4071070b]
@en